Search Results - "SESSAREGO, M"

A hybrid multi-objective evolutionary algorithm for wind-turbine blade optimization by Sessarego, M., Dixon, K.R., Rival, D.E., Wood, D.H.

“…A concurrent-hybrid non-dominated sorting genetic algorithm (hybrid NSGA-II) has been developed and applied to the simultaneous optimization of the annual…”
Get full text

Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis by Balbi, G, Ferrera, F, Rizzi, M, Piccioli, P, Morabito, A, Cardamone, L, Ghio, M, Palmisano, G.L, Carrara, P, Pedemonte, S, Sessarego, M, De Angioletti, M, Notaro, R, Indiveri, F, Pistillo, M.P

“…Systemic sclerosis (SSc) is a complex and heterogeneous autoimmune disorder with a multi-factorial pathogenesis. Like other autoimmune disorders, the possible…”
Get full text

AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis by Ferrera, F, Rizzi, M, Sprecacenere, B, Balestra, P, Sessarego, M, Di Carlo, A, Filaci, G, Gabrielli, A, Ravazzolo, R, Indiveri, F

“…Abstract Mutations in the autoimmune regulator ( AIRE ) gene are responsible for autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED)…”
Get full text

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients by VISANI, G, BERNASCONI, P, FALZETTI, D, FANIN, R, GOBBI, M, ISIDORI, A, LEONI, F, LISO, V, MALAGOLA, M, MARTINELLI, G, MECUCCI, C, PICCALUGA, P. P, BONI, M, PETTI, M. C, RONDELLI, R, RUSSO, D, SESSAREGO, M, SPECCHIA, G, TESTONI, N, TORELLI, G, MANDELLI, F, TURA, S, CASTOLDI, G. L, CIOLLI, S, CLAVIO, M, COX, M. C, CUNEO, A, DEL POETA, G, DINI, D

“…We studied the impact of cytogenetics and kind of induction/consolidation therapy on 848 adult acute myeloid leukemia (AML) patients (age 15-83). The patients…”
Get full text

Reduced intensity thiotepa–cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age by Raiola, A. M., Van Lint, M. T., Lamparelli, T., Gualandi, F., Mordini, N., Berisso, G., Bregante, S., Frassoni, F., Sessarego, M., Fugazza, G., Di Stefano, F., Pitto, A., Bacigalupo, A.

“…Transplant‐related mortality (TRM) remains a major problem in older patients undergoing allogeneic haemopoietic stem cell transplants (HSCTs). We have…”
Get full text

Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia by Carella, A M, Cunningham, I, Lerma, E, Dejana, A, Benvenuto, F, Podestà, M, Celesti, L, Chimirri, F, Abote, M, Vassallo, F, Figari, O, Parodi, C, Sessarego, M, Valbonesi, M, Carlier, P, Prencipe, E, Gatti, A M, van den Berg, D, Hoffman, R, Frassoni, F

“…Mobilization of Philadelphia (Ph) chromosome-negative progenitors is now possible in many Ph1-positive chronic myelogenous leukemia (CML) patients who had…”
Get more information

Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation by BACIGALUPO, A, SORACCO, M, FIGARI, O, BENVENUTO, F, SESSAREGO, M, FUGAZZA, G, CARLIER, P, VALBONESI, M, VASSALLO, F, ABATE, M, VAN LINT, M. T, GUALANDI, F, LAMPARELLI, T, OCCHINI, D, MORDINI, N, BREGANTE, S

“…Donor lymphocyte infusions (DLI) were given between June 1990 and March 1996 to 18 patients with chronic myeloid leukemia (CML) for the treatment of…”
Get full text

Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse by Miglino, M, Berisso, G, Grasso, R, Canepa, L, Clavio, M, Pierri, I, Pietrasanta, D, Gatto, S, Varaldo, R, Ballerini, F, Verdiani, S, Casarino, L, DeStefano, F, Sessarego, M, Dominietto, A, Raiola, A M, Bregante, S, di Grazia, C, Gobbi, M, Bacigalupo, A

“…We developed a PCR-based method to monitor clonogenic IgH VDJ rearrangement as a possible predictor of relapse in patients with acute B-ALL after allogeneic…”
Get full text

Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two cases by Miglino, M, Varaldo, R, Colombo, N, Grasso, R, Clavio, M, Garuti, A, Aquino, S, Albarello, A, Sessarego, M, Gobbi, M

“…We carried out sequential molecular monitoring of different markers on two BCR-ABL positive ALL patients receiving a standard dose induction regimen, which was…”
Get more information

Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia by Carella, A M, Podesta, M, Frassoni, F, Raffo, M R, Pollicardo, N, Pungolino, E, Vimercati, R, Sessarego, M, Parodi, C, Rabitti, C

“…Twenty-five patients with CML (chronic phase (CP): 15 patients; accelerated phase (AP): 10 patients) at a median of 40 months after diagnosis and ineligible…”
Get more information

Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia by Bacigalupo, A, Van Lint, MT, Valbonesi, M, Lercari, G, Carlier, P, Lamparelli, T, Gualandi, F, Occhini, D, Bregante, S, Valeriani, A, Piaggio, G, Pitto, A, Benvenuto, F, Figari, O, De Stefano, G, Caimo, A, Sessarego, M

“…Thirty-one patients (median age, 44 years) with advanced hematologic malignancies were given thiotepa 15 mg/kg, and cyclophosphamide 120 (n = 14) or 150 (n =…”
Get full text

Menu price presentation influences on consumer purchase behavior in restaurants by Yang, Sybil S., Kimes, Sheryl E., Sessarego, Mauro M.

“…Empirical research on menu design and price presentation thus far has focused primarily on attitudinal affects on consumers and not necessarily on actual…”
Get full text

Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females by Spinelli, S, Chiodi, S, Bacigalupo, A, Brasca, A, Menada, M V, Petti, A R, Ravera, G, Gualandi, F, VanLint, M T, Sessarego, M

“…Seventy-nine females undergoing allogeneic BMT following conditioning with total body irradiation (TBI), were prospectively followed between March 1983 and…”
Get more information

Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy by PIAGGIO, G, PODESTA, M, FRASSONI, F, BACIGALUPO, A, PITTO, A, SESSAREGO, M, FIGARI, O, FUGAZZA, G, BENVENUTO, F, BRUNO, B, VAN LINT, M. T, TRUINI, M

“…Cytogenetic abnormalities and paroxysmal nocturnal haemoglobinuria (PNH) phenotype are frequent findings in aplastic anaemia patients treated with…”
Get full text

Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience by Bacigalupo, A, Zikos, P, Van Lint, M T, Valbonesi, M, Lamparelli, T, Gualandi, F, Occhini, D, Mordini, N, Bregante, S, Berisso, G, Vitale, V, Sessarego, M, Marmont, A M

“…This is a retrospective study of 97 patients who received either allogeneic bone marrow transplant (BMT) (n=52) or peripheral blood cell transplant (PBCT)…”
Get more information

Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients by Clavio, M, Gatto, S, Beltrami, G, Quintino, S, Canepa, L, Pierri, I, Galbusera, V, Carrara, P, Miglino, M, Varaldo, R, Ballerini, F, Venturino, C, Cerri, R, Risso, M, Balleari, E, Carella, A M, Sessarego, M, Ghio, R, Bacigalupo, A, Gobbi, M

“…Forty-three consecutive patients with de novo and untreated non M3 AML aged 60 or less entered the study. The mean age of patients was 50 (range 15-60). The…”
Get more information

Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin by LAMPARELLI, T, VAN LINT, M. T, DOMINIETTO, A, DI GRAZIA, C, BRUNO, B, SESSAREGO, M, CASARINO, L, VERDIANI, S, BACIGALUPO, A, GUALANDI, F, RAIOLA, A. M, BARBANTI, M, SACCHI, N, FICAI, G, GHINATTI, C, BREGANTE, S, BERISSO, G

“…Preparative regimens without total body irradiation (TBI) have been reported for alternative donor hemopoietic stem cell transplants (HSCT). Between 7…”
Get full text

First Line Therapy with Fludarabine Combinations in 42 Patients with Either Post Myelodysplastic Syndrome or Therapy Related Acute Myeloid Leukaemia by Clavio, Marino, Gatto, Simona, Beltrami, Germana, Cerri, Raffaella, Carrara, Paola, Pierri, Ivana, Canepa, Letizia, Miglino, Maurizio, Balleari, Enrico, Masoudi, Bahman, Damasio, Eugenio, Ghio, Riccardo, Sessarego, Mario, Gobbi, Marco

“…Acute myeloid leukaemias (AML) evolving from a myelodysplastic syndrome (MDS) or secondary to chemoradiotherapy frequently display unfavorable biologic…”
Get full text

High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma by Ballestrero, A, Clavio, M, Ferrando, F, Gonella, R, Garuti, A, Sessarego, M, Ghio, R, Gobbi, M, Patrone, F

“…The purpose of the present study was to evaluate the feasibility and the efficacy of employing a high-dose chemotherapy (HDT) regimen with tandem peripheral…”
Get more information

Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia by CORSETTI, M. T, LERMA, E, SESSAREGO, M, LI PIRA, G, MANCA, F, CARELLA, A. M, DEJANA, A, BASTA, P, FERRARA, R, BENVENUTO, F, VASSALLO, F, ABATE, M, PIAGGIO, G, PARODI, C

“…The Philadelphia (Ph) translocation t(9;22) results in the creation of the BCR-ABL gene, which is now regarded as central to the mechanism that underlies the…”
Get full text